Countries using and planning to introduce IPV July 2015 status report This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine IPV ID: 139629
Download Presentation The PPT/PDF document "Countries using and planning to introduc..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Countries using and planning to introduce IPVSlide2
Countries using and planning to introduce IPVJuly 2015 status report
This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV).
Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact
polio2@who.int
with any questions or updates on this data.
Definitions
Formal decision
to introduce:
The country has documentation of its decision
to introduce
IPV which has
been verified by the relevant WHO Regional
Office, or for GAVI eligible countries, a complete application for IPV has been submitted to the GAVI Secretariat.
Intent
to introduce:
The country has informally indicated that it plans to introduce IPV, e.g. planning an application
to
GAVI, or by requesting technical
assistance to
develop an
IPV introduction
plan.
Tracking
these
decisions and informal
intents provide an indication of the global trend towards meeting
the targets of the
Polio Eradication and Endgame Strategic Plan
.Slide3
Countries using IPV vaccine to dateand formal decision/intent to introduceSince January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Kiribati, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Pakistan & Sri Lanka (July 2015)
Data source: WHO/IVB Database, as of 06 July 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 6 July 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced * to date
(95 countries or 49%)
Formal commitment to introduce in 2015
(72 countries or 37%)
Intend to introduce in 2015
(4 countries or 2%)
Formal commitment to introduce in 2016
(23 countries or 12%)
Not Available / Not introduced / No Plans
Not applicable
*
Includes
introductions in
some
parts of the country
onlySlide4
Countries using IPV vaccine to date and introductions planned according to Gavi eligibility status
Data source: WHO/IVB Database, as of 06 July 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 6 July 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced* to date
(95 countries or 49%)
Gavi
countries with formal commitment to introduce in 2015-16
(57 countries or 29%)
Non
Gavi
countries with formal commitment to introduce in 2015-16
(38 countries or 20%)
Non
Gavi
countries with intent to introduce in 2015
(4 countries or 2%)
Not Available / Not introduced / No Plans
Not applicable
*
Includes
introductions in
some
parts of the country
only
Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Kiribati, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Pakistan & Sri Lanka (July 2015)Slide5
99
countries introducing IPV between 06 July
2015 and
March
2016
Tier
1 countries
are countries
with
cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countriesTier 2 countries
are countries with cVDPV 1/3 since 2000 or large /medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC
Source: WHO/UNICEF database as at
01 June 2015Grenada – Indonesia
– Mauritius – Nauru and Yemen
are introducing in 2015 but no
month of introduction available. Slide6
Tier 1 and 2 Countries using IPV vaccine to dateand formal decision to introduceTier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries
Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /Medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC
Since January 2013, the following Tier 1 and 2 countries have introduced IPV:
The Philippines (October 2014), China (December 2014), Nigeria (February 2015), DR Congo (April 2015) and Madagascar (May 2015)
Data source: WHO/IVB Database, as of 06 July 2015,
based on 35 tier 1 & 2 countries
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 6 July 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced* to date
(29 countries or 83%)
Formal commitment to introduce in 2015-16
(6 countries or 17%)
Not Applicable or not Tier 1 or 2 countries
*
Includes
introductions in
some
parts of the country
onlySlide7
Middle Income Countries using IPV vaccine to dateand formal/intent decision to introduce
Data source: WHO/IVB Database, as of 06 July 2015 based on 100middle income countries (MIC) as per last World Bank classificationMap production Immunization Vaccines and Biologicals (IVB),World Health Organization
Date of slide: 6 July 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced* to date
(39 countries or 39%)
Formal commitment to introduce in 2015
(48 countries or 48%)
Intend to introduce in 2015
(3 countries or 3%)
Formal commitment to introduce in 2016
(10 countries or 10%)
Not applicable / Not introduced / No Plans
Since January 2013, the following MIC have introduced IPV:
Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015);
M
aldives (March 2015) and Cote d'Ivoire, Kiribati, St Vincent and the Grenadines & Sudan (June 2015);
Bhutan, Pakistan & Sri Lanka (July 2015)
*
Includes
introductions in
some
parts of the country
onlySlide8
IPV introduction status and planned introductionby quarter by the end of 2015 status report
Data source: WHO/IVB Database, as of 06 July 2015Map production Immunization Vaccines and Biologicals (IVB),World Health Organization
Date of slide: 6 July 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced* to date
(95 countries or 49%)
Introduction planned in Q3 2015
(30 countries or 15%)
Introduction planned in Q4 2015
(42 countries or 22%)
Introduction planned in 2016 or planned in 2015 but month of introduction not known
(27 countries or 14%)
Not Available
Not applicable
*
Includes
introductions in
some
parts of the country
only
Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Kiribati, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Pakistan & Sri Lanka (July 2015)